Sanofi Q3 2012 - Interview with CFO Jérôme Contamine
Sanofi, a global and diversified healthcare leader, reports results for the third-quarter of 2012. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and outlook.
Click to watch the video: http://bit.ly/T8WMTB
Topics covered in the interview include:
- Q3 2012 Results
- Multiple Sclerosis
- Rare Diseases
- Austerity in Europe
- Emerging Markets
- R&D pipeline
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Company website: www.sanofi.com